Programme details | |
---|---|
Degree: | Master of Science (MSc) |
Discipline: |
Pharmacy
|
Duration: | 24 months |
ECTS points: | 120 |
University website: | Pharmaceutical Research, Development and Safety |
Annual tuition (EEA) | tuition-free |
Annual tuition (non-EEA) | ca. 146,700 HKD University currency: 18,000 EUR This applies to citizens of Hong Kong |
Request information from the University of Helsinki
The aim of the Master’s Programme in Pharmaceutical Research, Development and Safety (MPHARM) is to provide a comprehensive overview of the life cycle of drugs and their use.
The academic activities in the personal study plan provide 120 credits (ECTS), the equivalent to two years of full-time studying. The target degree earned by the studies is Master of Science. In contrast to degree programme yielding Master in Pharmacy degree, this does not qualify for legalized healthcare professional status in the EU area. The courses are taught by an international faculty of world class scientists in a research oriented environment using state of the art pedagogical methods and incorporates their cutting edge research into the learning material.
The ageing population and the need for rapidly evolving medication solutions are factors that highlight the growing role and need of experts in pharmaceuticals, their use and regulatory processes in society.
In the Master’s Programme in Pharmaceutical Research, Development and Safety, you will:
Please note that the degree earned in this programme does not qualify for legalized healthcare professional status in the EU area.
After completing the M.Sc. Degree in pharmaceutical research, development and safety, the students:
Knowledge
Skills
Find more information on the website of the University of Helsinki: